Arm shares extend weekly rally to almost 50%, and Starbucks pulls the plug on an AI project
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
New data boosts our confidence in Lilly’s obesity pill. Plus, Google’s new AI
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Jim Cramer Left Stunned By UnitedHealth (UNH)
We recently published Jim Cramer’s Latest Thoughts On Cisco, NVIDIA & Other AI Stocks. UnitedHealth Group Incorporated (NYSE:UNH)…
Cramer backs Nvidia selling AI chips in China
CNBC’s Jim Cramer said Nvidia should be allowed to sell artificial intelligence chips into China, arguing the U.S.…
The case for owning cybersecurity stocks in the age of AI just got stronger
The case for owning cybersecurity stocks in the age of artificial intelligence just got stronger after new evidence…
Affirm CEO says ‘the American consumer is unbelievably resilient’
Affirm CEO Max Levchin told Jim Cramer the American consumer remains strong, even as concerns about the economy…
S&P 500 extends winning streak to 6 weeks. What drove the stock market gains
Another superb week for stocks is in the books. The S & P 500 and Nasdaq rallied on…
Nvidia CEO says AI partnership with Corning will ‘revitalize American manufacturing’
Nvidia CEO Jensen Huang told CNBC’s Jim Cramer that the company’s new partnership with Corning represents an important…
Big Tech cannot afford to be cheap on AI spending
Cloud computing giants cannot afford to pinch pennies on the artificial intelligence buildout, CNBC’s Jim Cramer argued Wednesday.…
Why Boeing and Honeywell are rallying, plus the AI trade gets a boost
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Andy Jassy says Amazon investors will be rewarded by its AI spending
Andy Jassy said Amazon’s massive spending on artificial intelligence isn’t something investors should fear — it’s exactly why…
Cardinal Health’s sell-off was an overreaction. We’d be buyers
We’ve taken a closer look at Cardinal Health’s quarterly results and conference call following Thursday’s sell-off. Our conclusion:…